Patent: 10,472,403
Summary for Patent: 10,472,403
| Title: | Proteolytic digestion of cardiac troponin I |
| Abstract: | A fluid sample container comprising a protease, when a sample fluid is placed in the fluid sample container the protease breaking a target analyte in the sample fluid into at least two peptides, the at least two peptides being smaller than the original target analyte. |
| Inventor(s): | David Ledden, Eric Cowden |
| Assignee: | Siemens Healthcare Diagnostics Inc |
| Application Number: | US15/535,964 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,472,403
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Genentech, Inc. | ACTEMRA | tocilizumab | Injection | 125276 | January 8, 2010 | ⤷ Start Trial | 2035-12-23 |
| Csl Behring Lengnau Ag | AFSTYLA | antihemophilic factor (recombinant), single chain | For Injection | 125591 | May 25, 2016 | ⤷ Start Trial | 2035-12-23 |
| Csl Behring Lengnau Ag | AFSTYLA | antihemophilic factor (recombinant), single chain | For Injection | 125591 | March 31, 2017 | ⤷ Start Trial | 2035-12-23 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,472,403
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 3237910 | ⤷ Start Trial |
| European Patent Office | 3575798 | ⤷ Start Trial |
| United States of America | 2017369544 | ⤷ Start Trial |
| United States of America | 2020031889 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2016105575 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
